Corcept Therapeutics Incorporated.
CORT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development, and commercialization of drugs to treat severe metabolic, oncologic, and psychiatric disorders by modulating the effects of cortisol. Its lead product, Korlym (mifepristone), is used to treat hypergl...Show More
Better Health for All
0
No relevant and verifiable evidence was found across the provided articles to assess Corcept Therapeutics Incorporated against the 'Better Health for All' ethical value. All articles either contained no data, were inaccessible (404 error), or pertained to a different company.
Fair Money & Economic Opportunity
0
No evidence available to assess Corcept Therapeutics Incorporated on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess Corcept Therapeutics Incorporated on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No quantitative data relevant to fair trade and ethical sourcing metrics, such as fair trade certifications, audit frequency, forced labor incidents, traceability, remediation speed, ethical clauses, materials risk, or supplier diversity spend, was provided in the available article.
1
Honest & Fair Business
0
Corcept Therapeutics has a formal whistleblower policy that requires employees to report alleged violations of policy to management or the Compliance Officer without fear of retaliation.
1
Reports can be made in-person, by telephone via a 24/7 Compliance Hotline, in writing, or directly to the Audit Committee.
2
However, there is no evidence provided regarding independent investigation processes for these reports. The company's financial statements are 100% covered by independent external audit, as indicated by the inclusion of audited financial statements.
3
Corcept has a Comprehensive Compliance Program (CCP) to prevent and detect violations of law or company policy, which includes at least an annual auditing and monitoring plan.
4
The company is committed to conducting its global business based on the highest ethical standards and adheres to federal and state healthcare fraud and abuse laws, including the Anti-Kickback Statute.
5
However, the frequency of training for this policy and metrics on its effectiveness are not specified. The company has had zero financial restatements in the past five years.
6
Kind to Animals
-50
Corcept Therapeutics is listed as one of over 40 private sector partners in the Validation Qualification Network (VQN), a public-private partnership focused on New Approach Methodologies (NAMs).
1
This indicates regular participation in collaborative initiatives with a modest financial contribution. However, the company has no public position on animal welfare legislation or industry standards, as no such engagement is mentioned in the provided articles.
No War, No Weapons
0
No evidence available to assess Corcept Therapeutics Incorporated on No War, No Weapons.
Planet-Friendly Business
-20
Corcept Therapeutics has no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided ESG data summaries, indicating zero environmental compliance violations.
1
Respect for Cultures & Communities
0
The provided articles do not contain any specific, concrete data points or information relevant to Corcept Therapeutics' performance regarding 'Respect for Cultures & Communities'. The articles discuss employment opportunities, overall ESG risk ratings, and investor relations, but lack details on community engagement, partnerships, cultural impact assessments, local employment, grievance mechanisms, or any other metrics related to this ethical value.
1
Safe & Smart Tech
0
The company's 2024 10-K filing reported no data breaches or unauthorized data use incidents that affected business strategy, results, or financial condition.
1
It also stated that multi-factor authentication is used, and that penetration testing and third-party assessments are performed for vulnerability management and security testing.
2
However, no specific metrics or details were provided to assess the scope, frequency, or effectiveness of these measures.
3
Zero Waste & Sustainable Products
0
No specific, concrete data points for any of the Zero Waste & Sustainable Products KPIs were found in the provided articles.
1
The articles were placeholders and explicitly stated a lack of relevant information regarding CORT.US's waste management, product design, packaging, or related sustainability practices.
2